Our new Review on Takayasu Arteritis, a collaborative effort with Amr H. Sawalha, Kaitlin A. Quinn and Peter C. Grayson from USA, Durga P. Misra and Ruchika Goel from India and my co-worker Fatma Alibaz-Öner from Turkey is published. Thanks to all my collaborators..
Are you living with an #autoimmune disease? If you are >18, share your experience in the COVAD-3 survey to help understand your lived experience
Link:https://t.co/aO4DT9el7G
We’d love to reach as many people as possible! @TheMyositisAssc@MyositisSupport@UKMyositis#myositis
All researchers with experience of applying to #Research#Ethics Committees (REC) are invited to complete the questionnaire. It may help revise the structure and improve REC functions across countries.
Please complete and RT, thank you! 😊
👉https://t.co/JKkfQTpQQV
Although mRNA vaccines develop satisfactory immunogenicity at 1 month and 3 months post-vaccination in adolescents with JIA on TNFi, SARS-CoV-2 antibody titres decrease significantly overtime, remaining at lower levels at 6 months. https://t.co/q9UaD9wlnx @RheumJnl
Russian missiles struck the beautiful peaceful Ukrainian city of Vinnytsia, killing 23 people. This medical center was completely destroyed. Doctors and patients, including small children, were killed.
This is an open act of terrorism!!
#StopWarInUkraine
Preito-Pena at al. Tocilizumab in LVV-GCA and TAK. Similar responses in both, with 75% showing complete clinical response but only 20% complete imaging response at month 12. Clinical implications of these persistent imaging findings need clarification @RheumNow#EULAR2022 POS0804